Effect of FK 506 on spontaneous diabetes in BB rats

Diabetes. 1990 Dec;39(12):1584-6. doi: 10.2337/diab.39.12.1584.

Abstract

From days 30-120 after birth, 59 BB rats were treated with water (n = 20) or FK 506 in intragastric doses of 1 mg.kg-1.day-1 (n = 19) or 2 mg.kg-1.day-1 (n = 20). Diabetes developed in 75, 15, and 0% of the 3 groups, respectively. Animals protected from diabetes by FK 506 had normal intraperitoneal glucose tolerance tests, virtual absence histopathologically of autoimmune insulitis, and normal pancreatic insulin content. Forty-five to 75 days after stopping FK 506, approximately 75% of the rats that were diabetes free at 120 days remained so.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology*
  • Autoimmune Diseases / pathology
  • Autoimmune Diseases / prevention & control
  • Blood Glucose / analysis
  • Cyclosporins / pharmacology
  • Diabetes Mellitus, Experimental / pathology
  • Diabetes Mellitus, Experimental / prevention & control*
  • Dose-Response Relationship, Drug
  • Glucose Tolerance Test
  • Guinea Pigs
  • Immunosuppressive Agents / pharmacology*
  • Insulin / analysis
  • Interleukin-2 / genetics
  • Interleukin-3 / genetics
  • Pancreas / chemistry
  • Pancreas / pathology
  • RNA, Messenger / drug effects
  • RNA, Messenger / genetics
  • Radioimmunoassay
  • Rats
  • Rats, Inbred BB
  • Rats, Inbred Strains
  • Tacrolimus
  • Transcription, Genetic / drug effects

Substances

  • Anti-Bacterial Agents
  • Blood Glucose
  • Cyclosporins
  • Immunosuppressive Agents
  • Insulin
  • Interleukin-2
  • Interleukin-3
  • RNA, Messenger
  • Tacrolimus